Verastem, Inc.

VSTM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $205.0M $88.8M $77.9M $74.9M $21.3M $67.8M $43.5M $129.9M
Accounts Receivable — — — — — — — —
Inventory $1.8M — — — — — $3.1M $327.0K
Total Current Assets $223.4M $95.0M $143.7M $92.9M $105.7M $144.9M $85.0M $253.3M
Property, Plant & Equipment — $32.0K $37.0K $92.0K $210.0K $416.0K $947.0K $1.4M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $16.4M — — — — — $20.0M $21.6M
Total Assets $246.4M $101.5M $149.7M $95.1M $108.7M $154.3M $145.0M $277.2M
Liabilities
Accounts Payable $12.4M $4.0M $7.2M $4.9M $2.3M $1.9M $9.7M $10.3M
Total Current Liabilities $72.3M $31.0M $26.4M $21.7M $18.6M $17.1M $29.9M $37.1M
Long-Term Debt — $40.7M $40.1M $24.5M — — — —
Total Liabilities $189.2M $130.4M $71.2M $47.7M $21.1M $39.1M $137.9M $152.9M
Stockholders' Equity
Retained Earnings $-1.16B $-955.5M $-824.9M $-737.5M $-663.7M $-592.5M $-524.8M $-375.6M
Total Stockholders' Equity $57.2M $-28.9M $57.4M $47.4M $87.6M $115.3M $7.2M $124.3M
← Newer Page 1 of 2 Older →